Skip to content

Clinical trials

Adenocarcinoma, Mucinous trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma, Mucinous Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20091
20131
20173
20181
20191
20211
20223
20231
20244
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Unknown status5
Active, not recruiting4
Completed3
Terminated3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center5
Royal Marsden NHS Foundation Trust3
National Cancer Institute (NCI)2
Andreana Holowatyj, PhD, MSCI1
Apollo Therapeutics Ltd1
Appendix Cancer Pseudomyxoma Peritonei Research Foundation1
Brown University1
City of Hope Medical Center1
Guangdong Provincial People's Hospital1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma, Mucinous24
Colorectal Neoplasms7
Neoplasms5
Neoplasms, Cystic, Mucinous, and Serous5
Pseudomyxoma Peritonei5
Carcinoma4
Ovarian Neoplasms4
Stomach Neoplasms4
Adenocarcinoma3
Appendiceal Neoplasms3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.